Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIIB Pilot Study Of Efficacy And Safety Of Anidulafungin In The Treatment Of Candidemia In Asian Patients

NCT00537329 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00537329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00537329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIIB Pilot Study Of Efficacy And Safety Of Anidulafungin In The Treatment Of Candidemia In Asian Patients
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
March 31, 2009
Enrollment
43 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

candidemia